Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Trial With Mesalamine 1g Suppositories

This study has been terminated.
(Enrollment difficulties)
Sponsor:
Information provided by:
Sandoz Inc.
ClinicalTrials.gov Identifier:
NCT01172444
First received: July 28, 2010
Last updated: September 21, 2012
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)